Key facts
- Asto CT’s last known valuation is $266.5M (Jun 2025).
- It has raised $122.8M across 5 recorded rounds; the latest was Early Stage VC ($26.7M) in Apr 2026.
- Notable investors include Alumni Ventures, Serra Ventures, Wisconsin Economic Development, Mediquip (Australia), Photo Diagnostic Systems.
- Asto CT has filed 11 Form Ds with the SEC since 2016, most recently Apr 2026 ($26.7M sold to 13 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Asto CT
Funding rounds
5 roundsAbout Asto CT
Developer of computed tomography (CT) device designed to provide standard whole-body scanning of animals. The company's device is an x-ray CT imaging equipment that provides rapid 3D imaging of the lower limbs and head without subjecting the horses to general anesthesia, to provide underload and diagnostic quality images, enabling veterinarians to treat animals in an enhanced way.
- Sector
- Business Products and Services (B2B)
- HQ
- Middleton, WI, United States
- Founded
- 2015
- Employees
- 12
- Website
- astoct.com/
- Ownership
- Privately Held (backing)
Asto CT doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Asto CT shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Asto CT in its N-PORT filings yet. We sweep new filings monthly.